Enorama Pharma AB (publ) (ERMA.ST)
- Previous Close
2.7800 - Open
2.7500 - Bid 2.3200 x --
- Ask 2.7000 x --
- Day's Range
2.3200 - 2.7500 - 52 Week Range
1.7100 - 8.4800 - Volume
24 - Avg. Volume
250,509 - Market Cap (intraday)
162.673M - Beta (5Y Monthly) 1.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company was incorporated in 2006 and is based in Malmö, Sweden.
www.enorama.se5
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ERMA.ST
View MorePerformance Overview: ERMA.ST
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ERMA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ERMA.ST
View MoreValuation Measures
Market Cap
168.12M
Enterprise Value
166.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.66
Price/Book (mrq)
21.55
Enterprise Value/Revenue
10.53
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-277.82%
Return on Assets (ttm)
-118.33%
Return on Equity (ttm)
-320.44%
Revenue (ttm)
15.77M
Net Income Avi to Common (ttm)
-43.81M
Diluted EPS (ttm)
-0.7200
Balance Sheet and Cash Flow
Total Cash (mrq)
2.08M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-34.96M